Why is Cerebras Systems stock sliding to a new 52-week low today?

Cerebras shares fell 8.0% to a 52-week low of $148.50 and are down more than 60% from their $386.34 IPO-debut high. The pressure includes an industry report suggesting OpenAI’s GPT-6.1 Sol inference tier uses Nvidia GPUs, plus about 19.4 million shares becoming eligible for sale around October 14, 2026. The stock is below its $185 IPO price; analysts’ average price target remains well above the current level, but the next earnings report is not expected until early December.

Analysis

The key risk is not that one reported OpenAI inference tier uses Nvidia GPUs; it is that investors may lower the probability that Cerebras converts its strategic relationship into durable, repeatable workloads. Do not extrapolate one tier to the entire multi-year agreement: verify deployment scope, committed capacity, and any change to contract economics. If workloads migrate, the second-order damage is weaker proof of Cerebras’ differentiated fit for inference, potentially pressuring future customer wins and bargaining power. Nvidia is the clear relative beneficiary of the reported workload, but one deployment is not evidence of a material change to its consolidated outlook.

Near term (days), eligible shares create potential supply, not guaranteed selling; prior insider transactions can amplify positioning anxiety without proving further sales. With the stock already sharply derated, a crowded short can face a squeeze if actual turnover is modest or OpenAI clarifies continued Cerebras use. Over 1–3 months, the important checks are unlock-related volume/ownership changes and any customer or company disclosure before December results. Over 6–18 months, product competitiveness and customer diversification matter more than the unlock.

Contrarian point: the market may be treating a workload-level signal as evidence against the whole customer relationship, while also discounting future equity supply before it is sold. Conversely, a broken chart alone is not a valuation floor. Missing data include the contract’s hardware and revenue scope, share borrow/short interest, options pricing, and actual post-unlock sales.

Key Decisions for Investors

• Avoid adding to an outright CBRS short solely on the reported workload and unlock: the stock’s large decline raises squeeze risk, and neither a contract reduction nor actual insider selling is established.
• For a tactical bearish expression, consider a defined-risk CBRS put spread only if implied volatility and liquidity make the premium acceptable; initiate after confirming the October 14 unlock mechanics and monitor actual selling/volume rather than treating eligibility as distribution.
• Do not pair this as a material long-NVDA/short-CBRS trade on this evidence alone. Revisit only if reporting confirms broader Cerebras workload displacement or a meaningful change in OpenAI commitments.
• Falsification/cover trigger: credible confirmation that OpenAI continues deploying Cerebras across substantial workloads, no meaningful post-unlock supply, or CBRS guidance indicating intact customer commitments. Escalation trigger: verified contract-scope reduction, material customer concentration deterioration, or sustained selling after unlock.